Lukas Biomedical Inc. (6814.TWO)
TWD 30.05
(0.0%)
TWD 30.05
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 161.05 Million TWD | 5.83% |
| 2022 | 152.18 Million TWD | -37.78% |
| 2021 | 244.56 Million TWD | 5.08% |
| 2020 | 232.73 Million TWD | -8.63% |
| 2019 | 254.7 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 199.98 Million TWD | 24.17% |
| 2024 Q2 | 199.98 Million TWD | 0.0% |
| 2023 Q4 | 161.05 Million TWD | 0.0% |
| 2023 Q3 | 161.05 Million TWD | 4.83% |
| 2023 Q2 | 153.63 Million TWD | 0.0% |
| 2023 Q1 | 153.63 Million TWD | 0.95% |
| 2022 FY | 152.18 Million TWD | -37.78% |
| 2022 Q4 | 152.18 Million TWD | 0.0% |
| 2021 FY | 244.56 Million TWD | 5.08% |
| 2020 FY | 232.73 Million TWD | -8.63% |
| 2019 FY | 254.7 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -29.127% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 56.273% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -1920.309% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 50.967% |
| NaviFUS Corp. | 53.4 Million TWD | -201.603% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -34.373% |
| TaiRx, Inc. | 60.62 Million TWD | -165.664% |
| Sinew Pharma Inc. | 39.71 Million TWD | -305.547% |
| Lin BioScience, Inc. | 167.73 Million TWD | 3.977% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -2333.651% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 29.265% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -2202.817% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 72.397% |
| AP Biosciences Inc | 106.65 Million TWD | -51.016% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 78.027% |
| RBC Bioscience Corporation | 513.08 Million TWD | 68.609% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 83.475% |
| EirGenix Inc. | 1.14 Billion TWD | 85.935% |
| Enimmune corporation | 173.46 Million TWD | 7.151% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -282.037% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -424.947% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 87.871% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 87.828% |
| TCI GENE Inc. | 155.54 Million TWD | -3.543% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -658.782% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 81.411% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1636.298% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -155.511% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 18.439% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -188.569% |
| Neith Corporation | 17.43 Million TWD | -823.874% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 68.57% |
| VBI | 21.25 Million TWD | -657.889% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 30.864% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 48.659% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -592.578% |
| CHO Pharma, Inc. | 110.83 Million TWD | -45.318% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -177.501% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -531.406% |
| Visgeneer Inc. | 185.6 Million TWD | 13.225% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 55.811% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -43.827% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 66.55% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -16.858% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -71.862% |
| GlycoNex Incorporation | 276.39 Million TWD | 41.73% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 95.438% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 17.823% |
| PharmaEngine, Inc. | 91 Million TWD | -76.976% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 89.563% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 68.705% |
| BiOptic Inc. | 170.56 Million TWD | 5.572% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -45.177% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -248.801% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -148.215% |
| OBI Pharma, Inc. | 650.44 Million TWD | 75.239% |
| Savior Lifetec Corporation | 457.95 Million TWD | 64.831% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -500.675% |
| Level Biotechnology Inc. | 273.2 Million TWD | 41.047% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 92.829% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 58.789% |
| Acepodia, Inc. | 384.47 Million TWD | 58.109% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -88.256% |